Breast Cancer Panel - Disclosures as of 9/2/2010
View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures| Panel Member | Clinical Research Support | Advisory Boards, Speakers Bureau, Expert Witness, or Consultant | Patent, Equity, or Royalty | Other | Date Completed |
|---|---|---|---|---|---|
Craig Allred, MD |
None |
None |
Clarient, Inc |
None |
1/15/2010 |
Benjamin O. Anderson, MD |
General Electric; |
Wyeth Pharmaceuticals |
None |
None |
7/18/2010 |
Harold J. Burstein, MD, PhD |
None |
None |
None |
None |
10/29/2009 |
Robert W. Carlson, MD |
AstraZeneca Pharmaceuticals LP; |
AstraZeneca Pharmaceuticals LP; |
None |
None |
10/29/2009 |
W. Bradford Carter, MD |
None |
None |
None |
None |
12/2/2009 |
Stephen B. Edge, MD |
None |
None |
None |
None |
12/21/2009 |
John K. Erban, MD |
None |
Macrogenics; |
None |
None |
7/22/2009 |
William B. Farrar, MD |
None |
None |
None |
None |
10/29/2009 |
Andres Forero, MD |
Biogen Idec; |
None |
None |
None |
9/28/2009 |
Lauren Gallagher, RPh, PhD |
None |
None |
None |
None |
8/23/2010 |
Sharon Hermes Giordano, MD, MPH |
None |
None |
None |
None |
11/3/2009 |
Lori J. Goldstein, MD |
AstraZeneca Pharmaceuticals LP; |
Amgen Inc.; |
None |
None |
11/4/2009 |
William J. Gradishar, MD |
None |
Abraxis Bioscience, Inc.; |
None |
None |
7/19/2010 |
Kristina M. Gregory, RN, MSN, OCN |
None |
None |
None |
None |
8/30/2010 |
Daniel F. Hayes, MD |
AstraZeneca Pharmaceuticals LP; |
Chugai Pharmaceuticals; |
Halcyon Diagnostics, Inc; |
None |
5/26/2010 |
Clifford A. Hudis, MD |
Genentech, Inc.; |
Bayer HealthCare; |
None |
None |
7/1/2009 |
Britt-Marie E. Ljung, MD |
National Cancer Institute |
Versant ventures |
None |
None |
7/7/2009 |
David A. Mankoff, MD, PhD |
Merck & Co., Inc.; |
Genzyme Corporation |
None |
None |
7/1/2010 |
P. Kelly Marcom, MD |
Bristol-Myers Squibb Company; |
AstraZeneca Pharmaceuticals LP; |
None |
None |
12/16/2009 |
Ingrid A. Mayer, MD |
None |
None |
None |
None |
7/1/2009 |
Joan S. McClure, MS |
None |
None |
None |
None |
7/18/2010 |
Beryl McCormick, MD |
None |
None |
None |
None |
4/22/2010 |
Susan Moench, PhD |
None |
None |
None |
None |
7/29/2010 |
Lori J. Pierce, MD |
None |
None |
None |
None |
8/4/2009 |
Elizabeth C. Reed, MD |
None |
UnitedHealthcare |
None |
None |
11/2/2009 |
Jasgit Sachdev, MD |
Abraxis Oncology; |
Genomic Health, Inc.; |
None |
None |
4/6/2010 |
Dorothy Shead, MS |
None |
None |
None |
None |
7/18/2010 |
Mary Lou Smith, JD, MBA |
None |
Eli Lilly and Company |
None |
None |
12/30/2009 |
George Somlo, MD |
American BioSciences Inc.; |
Bristol-Myers Squibb Company; |
None |
None |
11/2/2009 |
John H. Ward, MD |
None |
Strategic Consultants International |
None |
None |
7/3/2009 |
Eric P. Winer, MD |
Genentech, Inc. |
None |
None |
None |
9/30/2009 |
Antonio C. Wolff, MD |
Genentech, Inc.; |
None |
None |
None |
11/2/2009 |
Richard Zellars, MD |
Pending |
Privacy Policy| Legal Notices| Site Map| Contact Us| Help
Copyright © 2010 National Comprehensive Cancer Network, All Rights Reserved